News at CenExel

FDA Approves ABRYSVO for RSV

In the last week, the FDA approved the first maternal vaccine designed to safeguard infants from respiratory syncytial virus (RSV) during the critical period immediately from birth up to 6 months of age, when they are most vulnerable to infection. RSV, a highly...

Preventing and Treating Bunions and Ingrown Toenails

Preventing and Treating Bunions and Ingrown Toenails

As a CenExel Center of Excellence, JBR works with patients who are managing challenging conditions, such as bunions. As a medical researcher in pain management, I have worked with many individuals that have participated in a bunion surgery at our surgical center in SLC, UT, and over the years I have developed a list of preventative treatments that I recommend to patients after surgery to help them keep their feet and toes happy and healthy. Here are my top tips for healthy feet . . .

Cali Biosciences Phase 2b Study on Post-Operative Pain

SAN DIEGO, August 12, 2021 /PRNewswire/ -- Cali Biosciences Co., Ltd. (hereinafter referred to as "CaliBio"), a global biopharmaceutical company focused on the research and development of innovative drugs, announced it has initiated a Phase 2b study of its...

Heron Therapeutics Publication on ZYNRELEF™

Heron Therapeutics Announces Publication Showing Reduction of Pain and Opioid Use Compared to Bupivacaine in Patients 65 and Older with ZYNRELEF™ SAN DIEGO, July 21, 2021 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company...

Heron Therapeutics Approval of ZYNRELEF™

Heron Therapeutics Announces U.S. FDA Approval of ZYNRELEF™ (HTX-011) for the Management of Postoperative Pain for up to 72 Hours - ZYNRELEF is the first and only FDA-approved extended-release dual-acting local anesthetic, clinically proven to manage pain and to...